R87.811
BillableVaginal high risk human papillomavirus (HPV) DNA test positive
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is R87.811 an HCC code?
No. R87.811 is a billable ICD-10-CM code but does not map to any HCC category in V28, V24, ESRD, or RxHCC.
This code does not map to an HCC category in any model (V28, V24, ESRD, RxHCC).
What This Code Means
R87.811 is the ICD-10-CM diagnosis code for vaginal high risk human papillomavirus (hpv) dna test positive. A positive test result for high-risk types of human papillomavirus (HPV) DNA detected in a vaginal sample, indicating potential increased risk for genital cancer. R87.811 sits in the ICD-10-CM chapter for symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (r00-r99), within the section covering abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (r83-r89).
R87.811 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.
Distinguish between cervical (R87.810) and vaginal (R87.811) HPV testing; verify specimen source in the report.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for R87.811 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Distinguish between cervical (R87.810) and vaginal (R87.811) HPV testing; verify specimen source in the report
- •High-risk HPV positivity may trigger additional screening or treatment protocols depending on clinical guidelines